Identifíquese
¿Aún no es suscriptor de la revista?
Comprar el acceso al artículo
Comprando el artículo el pdf del mismo podrá ser descargado
Teléfono para incidencias
De lunes a viernes de 9h a 18h (GMT+1) excepto los meses de julio y agosto que será de 9 a 15h
Llamadas desde España
932 415 960
Llamadas desde fuera de España
+34 932 415 960
Bibliografía
[1.]
S. Epstein, D. Leroith.
Diabetes and fragility fractures – A burgeoning epidemic?.
Bone, (2008), 43 pp. 3-6
[2.]
L.C. Hofbauer, C.C. Brueck, S.K. Singh, H. Dobnig.
Osteoporosis in patients with diabetes mellitus.
J Bone Miner Res, (2007), 22 pp. 1317-1328
[3.]
M. Janghorbani, R.M. Van Dam, W.C. Willett, F.B. Hu.
Systematic review of type 1 and type 2 diabetes mellitus and risk of fracture.
Am J Epidemiol, (2007), 166 pp. 495-505
[4.]
G. Valerio, A. del Puente, A. Esposito-del Puente, P. Buono, E. Mozzillo, A. Francese.
The lumbar bone mineral density is affected by long-term poor metabolic control in adolescents with type 1 diabetes mellitus.
Horm Res, (2002), 58 pp. 266-272
[5.]
M. Muñoz-Torres, E. Jodar, F. Escobar-Jiménez, P.J. López-Ibarra, J.D. Luna.
Bone mineral density measured by dual X-ray absorptiometry in Spanish patients with insulindependent diabetes mellitus.
Calcif Tissue Int, (1996), 58 pp. 316-319
[6.]
N.B. Kharzai, G.R. Beck, G.E. Umpierrez.
Diabetes and fractures: an overshadowed association.
Curr Opin Endocrinol Diab Obes, (2009), 16 pp. 435-445
[7.]
L.J. Melton, C.L. Leibson, S.J. Achenbach, T.M. Therneau, S. Khosla.
Fracture risk in type 2 diabetes: update of a population-based study.
J Bone Miner Res, (2008), 23 pp. 1334-1342
[8.]
Muñoz-Torres, G. Alonso, M. Varsavsky.
Riesgo de fracturas en el paciente diabético.
Metab Óseo, (2008), 1 pp. 5-13
[9.]
A.V. Schwartz, T.A. Hillier, D.E. Sellmeyer, H.E. Resnick, E. Gregg, K.E. Ensrud, et al.
Older women with diabetes have a higher risk of falls: A prospective study.
Diabetes Care, (2002), 25 pp. 1749-1754
[10.]
S.E. Kahn, B. Zinman, M. John, J.M. Lachin, S.M. Haffner, W.H. Herman, For the A Diabetes Outcome Progression Trial (ADOPT) Study Group, et al.
Rosiglitazone-associated fractures in type 2 diabetes.
Diabetes Care, (2008), 31 pp. 845-851
[11.]
C. Meier, M.E. Kraenzlin, M. Bodmer, S.S. Jick, H. Jick, C.R. Meier.
Use of thiazolidinediones and fracture risk.
Arch Intern Med, (2008), 168 pp. 820-825
[12.]
P. Kannus, H. Sievannen, M. Palvanen, T. Jarvinen, J. Parkkari.
Prevention of falls and consequent injuries in elderly people.
Lancet, (2005), 366 pp. 1885-1893
[13.]
T.H. Keegan, A.V. Schwartz, D.C. Bauer, D.E. Sellmeyer, J.L. Kelsey.
Effect of alendronate on bone mineral density and biochemical markers of bone turnover in type 2 diabetic women: The Fracture Intervention Trial.
Diabetes Care, (2004), 27 pp. 1547-1553
[14.]
E. Murphy, G.R. Williams.
The thyroid and the skeleton.
Clin Endocrinol (Oxf), (2004), 61 pp. 285-298
[15.]
P. Vestergaard, L. Mosekilde.
Fractures in patients with hyperthyroidism and hypothyroidism: a nationwide follow-up study in 16,249 patients.
Thyroid, (2002), 12 pp. 411-419
[16.]
E.O. Abu, S. Bord, A. Horner, V.K. Chatterjee, J.E. Compston.
The expression of thyroid hormone receptors in human bone.
Bone, (1997), 21 pp. 137-142
[17.]
E. Abe, L. Sun, J. Mechanick, J. Iqbal, K. Yamoah, R. Baliram, et al.
Bone loss in thyroid disease: role of low TSH and high thyroid hormone.
Ann N Y Acad Sci, (2007), 116 pp. 383-391
[18.]
H. Karga, P.D. Papapetrou, A. Korakovouni, F. Papandroulaki, A. Polymeris, G. Pampouras.
Bone mineral density in hyperthyroidism.
Clin Endocrinol (Oxf), (2004), 61 pp. 466-472
[19.]
D.C. Bauer, B. Ettinger, M.C. Nevitt, K.L. Stone.
Risk for fracture in women with low serum levels of thyroid-stimulating hormone.
Ann Intern Med, (2001), 134 pp. 561-568
[20.]
W.Y. Lee, K.W. Oh, E.J. Rhee, C.H. Jung, S.W. Kim, E.J. Yun, et al.
Relationship between subclinical thyroid dysfunction and femoral neck bone mineral density in women.
Arch Med Res, (2006), 37 pp. 511-516
[21.]
K.A. Heemstra, N.A. Hamdy, J.A. Romijn, J.W. Smit.
The effects of thyrotropin-suppressive therapy on bone metabolism in patients with well-differentiated thyroid carcinoma.
Thyroid, (2006), 16 pp. 583-591
[22.]
A.C. Heijckmann, M.S. Huijberts, P. Geusens, J. de Vries, P.P. Menheere, B.H. Wolffenbuttel.
Hip bone mineral density, bone turnover and risk of fracture in patients on long-term suppressive L-thyroxine therapy for differentiated thyroid carcinoma.
Eur J Endocrinol, (2005), 153 pp. 23-29
Copyright ©
2010. Elsevier España, S.L.. Todos los derechos reservados
